Insider Activity of Carter Todd Alfred
According to the SEC Form 4 filings, Carter Todd Alfred, being in a position of
- Chief Scientific Officer at Voyager Therapeutics, Inc.,оver the last 12 months, has bought 0 shares, and sold 11000 shares for $40,621,over all time since 2023-01-06, has bought 0 shares, and sold 50171 share for $350,868.
Biography of Carter Todd Alfred
No biography is available at this moment.